Penserra Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$103K	Buy	+3,444	New	+$111K	﹤0.01%	730
2025 Q2	–	Sell	-11,584	Closed	-$178K	–	1130
2025 Q1	$178K	Sell	11,584 -40,059	-78%	-$716K	﹤0.01%	752
2024 Q4	$1.14M	Buy	51,643 +42,152	+444%	+$767K	0.02%	375
2024 Q3	$171K	Sell	9,491 -151,859	-94%	-$2.66M	﹤0.01%	726
2024 Q2	$2.62M	Buy	161,350 +7,620	+5%	+$117K	0.03%	320
2024 Q1	$2.17M	Buy	+153,730	New	+$1.94M	0.03%	340
2018 Q4	–	Sell	-11,316	Closed	-$243K	–	777
2018 Q3	$243K	Buy	11,316 +1,599	+16%	+$37.1K	0.01%	393
2018 Q2	$236K	Buy	9,717 +673	+7%	+$13.7K	0.01%	299
2018 Q1	$154K	Buy	9,044 +714	+9%	+$13.9K	0.01%	271
2017 Q4	$157K	Buy	8,330 +1,309	+19%	+$19.7K	0.02%	235
2017 Q3	$129K	Buy	+7,021	New	+$158K	0.03%	238